Please Wait.....
Report
Clinical Trials Supply & Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Service (Logistics & Distribution; Storage & Retention; Packaging, Labeling, & Blinding; Manufacturing; Comparator Sourcing; Others), By Phase (Phase 0, Phase I, Phase II, Phase III), By Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Others), By End User Industry (Pharmaceutical v/s Medical Devices), By Company and By Region
Market Report I 2023-06-01 I 114 Pages I TechSci Research
The global clinical trials supply & logistics market is projected to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of various diseases and cancers, an upsurge in demand for personalized medicines, and extensive development in technology, which are fueling the market's growth. A clinical trial is a process in which several experiments, tests, or studies are performed on animals and humans to analyze the results. Clinical trials are split into two types that are observational studies and interventional trials. The other factors supporting the market's growth are the rise in research and development activities, increasing research and development expenditure, a large number of clinical trials and research studies, huge demand for vaccinations, the growing aging population, and growing inorganic growth strategies such as mergers, acquisitions, collaborations, and others by pharmaceutical and biologics industries.
Rising Emphasis on Drug Development
The growing frequency of various types of diseases such as obesity, cardiovascular, diabetes, infectious, and cancer is surging the demand for drug development, which is bolstering the growth of the market globally. For instance, according to WHO, around 422 million people around the world have diabetes. Owing to the surge in the number of people suffering from different types of diseases, the rise in demand for the development of new therapies, drugs, and medical devices is augmenting the growth of the market. According to the WHO, more than 80 vaccines are presently being analyzed in clinical trials, with over 180 in the pre-clinical stage. Moreover, rising funding for drug development by government and non-government organizations is a contributing factor to the growth of the market. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), PhRMA affiliates have invested considerably in drug development efforts.
Technological Advancements
Technological advancement and innovations in healthcare and medicine are driving the growth of the market. For instance, in South Korea, Asan Medical Center (AMC) has developed a new system capable of handling clinical trial image data from group to extraction. The increasing adoption of new innovative technologies, such as cloud-enabled digital core, machine learning algorithms, radio-frequency identification (RFID), blockchain-based product tracking, and use of the internet of things to improve the quality management of clinical trial supply and logistics operations, are impelling the growth of the market. Heavy investments by several companies in advanced technologies and logistics are propelling the growth of the market. For instance, in 2020, Almac Clinical Technologies, a section of the Almac Group, proposed Simplify, a next-generation IRT solution. It is enabled with a standard array of configurable functionality intended to speed up the study startup process.
Growing Demand for Precision Medicines
The growing prominence of personalized medicines is one of the key factors supporting the growth of the market. For instance, in 2020, according to the scope and significance of the progress report, specialized medicines reported for about 39 percent of the total FDA-approved new drugs in the year. The rising demand for precision drugs is due to their efficiency in treating unique and complex diseases. New drugs and disease therapies are being developed due to the rising need and use by doctors, researchers, and pharmaceutical firms, which facilitates the growth of the market.
Market Segmentation
The global clinical trials supply & logistics market is segmented into service, phase, therapeutic area, end-user industry, and company. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labeling, & blinding, manufacturing, comparator sourcing, and others. Based on phase, the market is segmented into Phase 0, phase I, phase II, and Phase III. Based on therapeutic areas, the market is divided into oncology, cardiovascular diseases, neurological disorders, and others. Based on the end-user industry, the market is divided into pharmaceutical and medical devices. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising occurrences of various types of cancer and extensive technology development in the country.
Market Players
Thermo Fisher Scientific (Patheon), Catalent, Inc., United Parcel Service (Marken), PARAXEL International Corporation, Almac Group, Piramal Pharma Solutions (Piramal Group), UDG Healthcare, plc, DHL International Limited, Packaging Coordinators Inc., and Walden Group SAS (Movianto) are some of the leading companies operating in the market.
Report Scope:
In this report, global clinical trials supply & logistics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Clinical Trials Supply & Logistics Market, By Service:
o Logistics & Distribution
o Storage & Retention
o Packaging
o Labeling & Blinding
o Manufacturing
o Comparator Sourcing
o Others
- Clinical Trials Supply & Logistics Market, By Phase:
o Phase 0
o Phase I
o Phase II
o Phase III
- Clinical Trials Supply & Logistics Market, By Therapeutic Area:
o Oncology
o Cardiovascular Diseases
o Neurological Disorders
o Others
- Clinical Trials Supply & Logistics Market, By End User Industry:
o Pharmaceutical
o Medical Devices
- Clinical Trials Supply & Logistics Market, By Region:
o North America
o United States
o Canada
o Mexico
o Asia-Pacific
o China
o India
o Japan
o Australia
o South Korea
o Europe & CIS
o Germany
o France
o United Kingdom
o Spain
o Italy
o South America
o Brazil
o Argentina
o Colombia
o Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Turkey
o Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Clinical Trials Supply & Logistics Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Clinical Trial Supply & Logistics Market
5. Voice of Customer
6. Global Clinical Trial Supply & Logistics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service (Logistics & Distribution; Storage & Retention; Packaging, Labeling, & Blinding; Manufacturing; Comparator Sourcing; Others)
6.2.2. By Phase (Phase 0, Phase I, Phase II, Phase III)
6.2.3. By Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Others)
6.2.4. By End User Industry (Pharmaceutical v/s Medical Devices)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7. North America Clinical Trial Supply & Logistics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Phase
7.2.3. By Therapeutic Area
7.2.4. By End User Industry
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Clinical Trial Supply & Logistics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Phase
7.3.1.2.3. By Therapeutic Area
7.3.1.2.4. By End User Industry
7.3.2. Canada Clinical Trial Supply & Logistics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Phase
7.3.2.2.3. By Therapeutic Area
7.3.2.2.4. By End User Industry
7.3.3. Mexico Clinical Trial Supply & Logistics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Phase
7.3.3.2.3. By Therapeutic Area
7.3.3.2.4. By End User Industry
8. Europe Clinical Trial Supply & Logistics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Phase
8.2.3. By Therapeutic Area
8.2.4. By End User Industry
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Clinical Trial Supply & Logistics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Phase
8.3.1.2.3. By Therapeutic Area
8.3.1.2.4. By End User Industry
8.3.2. Germany Clinical Trial Supply & Logistics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Phase
8.3.2.2.3. By Therapeutic Area
8.3.2.2.4. By End User Industry
8.3.3. United Kingdom Clinical Trial Supply & Logistics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Phase
8.3.3.2.3. By Therapeutic Area
8.3.3.2.4. By End User Industry
8.3.4. Italy Clinical Trial Supply & Logistics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Phase
8.3.4.2.3. By Therapeutic Area
8.3.4.2.4. By End User Industry
8.3.5. Spain Clinical Trial Supply & Logistics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Phase
8.3.5.2.3. By Therapeutic Area
8.3.5.2.4. By End User Industry
9. Asia-Pacific Clinical Trial Supply & Logistics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Phase
9.2.3. By Therapeutic Area
9.2.4. By End User Industry
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Clinical Trial Supply & Logistics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Phase
9.3.1.2.3. By Therapeutic Area
9.3.1.2.4. By End User Industry
9.3.2. India Clinical Trial Supply & Logistics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Phase
9.3.2.2.3. By Therapeutic Area
9.3.2.2.4. By End User Industry
9.3.3. Japan Clinical Trial Supply & Logistics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Phase
9.3.3.2.3. By Therapeutic Area
9.3.3.2.4. By End User Industry
9.3.4. South Korea Clinical Trial Supply & Logistics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Service
9.3.4.2.2. By Phase
9.3.4.2.3. By Therapeutic Area
9.3.4.2.4. By End User Industry
9.3.5. Australia Clinical Trial Supply & Logistics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Service
9.3.5.2.2. By Phase
9.3.5.2.3. By Therapeutic Area
9.3.5.2.4. By End User Industry
10. South America Clinical Trial Supply & Logistics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Phase
10.2.3. By Therapeutic Area
10.2.4. By End User Industry
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Clinical Trial Supply & Logistics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Phase
10.3.1.2.3. By Therapeutic Area
10.3.1.2.4. By End User Industry
10.3.2. Argentina Clinical Trial Supply & Logistics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Phase
10.3.2.2.3. By Therapeutic Area
10.3.2.2.4. By End User Industry
10.3.3. Colombia Clinical Trial Supply & Logistics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Phase
10.3.3.2.3. By Therapeutic Area
10.3.3.2.4. By End User Industry
11. Middle East and Africa Clinical Trial Supply & Logistics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Service
11.2.2. By Phase
11.2.3. By Therapeutic Area
11.2.4. By End User Industry
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Clinical Trial Supply & Logistics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Service
11.3.1.2.2. By Phase
11.3.1.2.3. By Therapeutic Area
11.3.1.2.4. By End User Industry
11.3.2. Saudi Arabia Clinical Trial Supply & Logistics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Service
11.3.2.2.2. By Phase
11.3.2.2.3. By Therapeutic Area
11.3.2.2.4. By End User Industry
11.3.3. UAE Clinical Trial Supply & Logistics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Service
11.3.3.2.2. By Phase
11.3.3.2.3. By Therapeutic Area
11.3.3.2.4. By End User Industry
11.3.4. Turkey Clinical Trial Supply & Logistics Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Service
11.3.4.2.2. By Phase
11.3.4.2.3. By Therapeutic Area
11.3.4.2.4. By End User Industry
11.3.5. Egypt Clinical Trial Supply & Logistics Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Service
11.3.5.2.2. By Phase
11.3.5.2.3. By Therapeutic Area
11.3.5.2.4. By End User Industry
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Thermo Fisher Scientific (Patheon)
14.2. Catalent, Inc.
14.3. United Parcel Service (Marken)
14.4. PARAXEL International Corporation
14.5. Almac Group
14.6. Piramal Pharma Solutions (Piramal Group)
14.7. UDG Healthcare, plc
14.8. DHL International Limited
14.9. Packaging Coordinators Inc.
14.10. Walden Group SAS (Movianto)
15. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security